The ZEPOSIA MS Pregnancy Registry

Are you pregnant and diagnosed with multiple sclerosis? Have you taken ZEPOSIA® (ozanimod) or other multiple sclerosis medications during your pregnancy?

Multiple sclerosis can be a debilitating condition. Help future pregnant women, doctors, and researchers understand the safety of medications that can provide some relief.

Are you a healthcare provider who treats pregnant women with multiple sclerosis?

Help us learn more about the safety of using ZEPOSIA® (ozanimod) and other multiple sclerosis medications during pregnancy.

About ZEPOSIA MS Pregnancy Registry

The goal of the ZEPOSIA MS Pregnancy Registry is to help doctors, patients, and researchers better understand the safety of ZEPOSIA® (ozanimod) and other multiple sclerosis medications used during pregnancy. Pregnant women in the United States or Canada with multiple sclerosis may be eligible to participate. The study collects health information from enrolled pregnant women and their healthcare providers related to their pregnancies and developing babies up to 1 year of age.

Would you like to participate?

Enroll in the Registry

Learn more about the Registry

ZEPOSIA MS Pregnancy Registry toll-free number

What is ZEPOSIA® (ozanimod)?

ZEPOSIA® (ozanimod) is a prescription medicine made by Celgene Corporation, a Bristol-Myers Squibb Company, that is used to treat relapsing forms of multiple sclerosis in adults.

Specifically, it is for the treatment of:

  • Clinically isolated syndrome
  • Relapsing-remitting disease
  • Active secondary progressive disease